• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number H060040A
Device Problem Break (1069)
Patient Problem Unspecified Infection (1930)
Event Date 02/27/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Review of device manufacturing record history confirmed device met pre-release specifications.Explant evaluation of returned specimen is currently in progress.
 
Event Description
On (b)(6) 2017, two gore® propaten® vascular grafts were implanted in an axillo-bifemoral procedure.On (b)(6) 2017, a reintervention procedure was performed due to femoro-femoral graft thrombosis.It was reported the physician was using a micropuncture needle for access, and the vascular graft tore apart.A section of the vascular graft was explanted and an interposition graft was placed.A section of the explanted vascular graft was sent to hospital lab for testing due to suspected infection.As reported, the test results were not available as the graft specimen was misplaced by user facility.A small section of the explanted vascular graft was returned to gore for evaluation.
 
Manufacturer Narrative
Review of device sterilization record history confirmed device met pre-release specifications.The explant evaluation state that gross and stereoscopic examination of the returned device fragment revealed no unusual characteristics outside those associated with the manipulation of the material with surgical instruments.All examined tissue specimens were consistent with scant deposition of unorganized fibrin admixed with variable amounts of erythrocytes, degenerate leukocytes, and nuclear debris.Calcification and infectious agents were not observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6447421
MDR Text Key71322348
Report Number2017233-2017-00173
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Catalogue NumberH060040A
Device Lot Number4622763PP031
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2017
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/23/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MICROPUNCTURE NEEDLE
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight86
-
-